Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression.
van Spronsen MF, Hanekamp D, Westers TM, van Gils N, Vermue E, Rutten A, Jansen JH, Lissenberg-Witte BI, Smit L, Schuurhuis GJ, van de Loosdrecht AA.
van Spronsen MF, et al. Among authors: van gils n, van de loosdrecht aa.
Leukemia. 2023 Mar;37(3):680-690. doi: 10.1038/s41375-023-01811-5. Epub 2023 Feb 15.
Leukemia. 2023.
PMID: 36792658
Free PMC article.